![William Chou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Chou
Verkställande Direktör på
PASSAGE BIO, INC.
Förmögenhet: 37 643 $ per 2026-05-31
Profil
Dr. William Chou is a President, Chief Executive Officer & Director at Passage Bio, Inc. He is on the Board of Directors at Passage Bio, Inc. Dr. Chou was previously employed as a Chief Executive Officer by Aruvant Sciences, Inc. and a Vice President by Novartis Pharma AG.
He received his undergraduate degree from Princeton University, an MBA from Yale School of Management and a doctorate degree from the University of Pittsburgh School of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PASSAGE BIO, INC. 0,2 % | 2026-03-16 | 6 524 ( 0,2 % ) | 37 643 $ | 2026-05-31 |
Aktiva positioner av William Chou
| Företag | Position | Start |
|---|---|---|
| PASSAGE BIO, INC. | Verkställande Direktör | 2022-10-10 |
Tidigare kända positioner av William Chou
| Företag | Position | Slut |
|---|---|---|
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Verkställande Direktör | 2022-10-01 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Företagsledare/Principal | 2019-10-01 |
William Chous utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
5
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Yale School of Management
 Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
